These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


815 related items for PubMed ID: 16704217

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM, Liu M, Yang JL, Guo XJ, Wang SC, Duan XY, Wang P.
    Chin Med J (Engl); 2007 Jan 05; 120(1):50-5. PubMed ID: 17254488
    [Abstract] [Full Text] [Related]

  • 5. A novel cholic acid-based contrast enhancement agent for targeted MRI.
    Chong HS, Song HA, Lim S, Macrenaris K, Ma X, Lee H, Bui P, Meade T.
    Bioorg Med Chem Lett; 2008 Apr 01; 18(7):2505-8. PubMed ID: 18337094
    [Abstract] [Full Text] [Related]

  • 6. Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents.
    Ferreira MF, Martins AF, Martins JA, Ferreira PM, Tóth E, Geraldes CF.
    Chem Commun (Camb); 2009 Nov 14; (42):6475-7. PubMed ID: 19841814
    [Abstract] [Full Text] [Related]

  • 7. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr 14; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Target visualization by MRI using the avidin/biotin amplification route: synthesis and testing of a biotin-Gd-DOTA monoamide trimer.
    Tei L, Barge A, Geninatti Crich S, Pagliarin R, Negri V, Ramella D, Cravotto G, Aime S.
    Chemistry; 2010 Jul 19; 16(27):8080-7. PubMed ID: 20533461
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo labeling of B16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent.
    Menchise V, Digilio G, Gianolio E, Cittadino E, Catanzaro V, Carrera C, Aime S.
    Mol Pharm; 2011 Oct 03; 8(5):1750-6. PubMed ID: 21780833
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K, Kikuchi K, Terai T, Komatsu T, Nagano T.
    Chemistry; 2008 Oct 03; 14(3):987-95. PubMed ID: 17992679
    [Abstract] [Full Text] [Related]

  • 14. Gd-functionalised Au nanoparticles as targeted contrast agents in MRI: relaxivity enhancement by polyelectrolyte coating.
    Warsi MF, Adams RW, Duckett SB, Chechik V.
    Chem Commun (Camb); 2010 Jan 21; 46(3):451-3. PubMed ID: 20066322
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M, Selegård L, Klasson A, Söderlind F, Abrikossova N, Skoglund C, Bengtsson T, Engström M, Käll PO, Uvdal K.
    Langmuir; 2010 Apr 20; 26(8):5753-62. PubMed ID: 20334417
    [Abstract] [Full Text] [Related]

  • 17. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
    Giesel FL, von Tengg-Kobligk H, Wilkinson ID, Siegler P, von der Lieth CW, Frank M, Lodemann KP, Essig M.
    Invest Radiol; 2006 Mar 20; 41(3):222-8. PubMed ID: 16481904
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.